TRIM47 promotes hypopharyngeal and laryngeal cancers progression through promoting K63‐linked ubiquitination of vimentin

Shichao Qin,Fen Chang,Xiangkai Sun,Zinan Li,Yin Wang,Dapeng Lei
DOI: https://doi.org/10.1111/cas.16397
IF: 5.7
2024-11-28
Cancer Science
Abstract:E3 ubiquitin ligase TRIM47 overexpresses in hypopharyngeal cancer and is related to poor prognosis. TRIM47 regulates vimentin which is associated with metastasis with K63‐linked ubiquitination in hypopharyngeal and laryngeal cancers. Hypopharyngeal and laryngeal cancers which belong to head and neck squamous cell carcinoma (HNSCC) are the two most malignant types of head and neck cancer, characterized by a low 5‐year survival rate, high recurrence and metastasis rate. It is vital to explore strategies to suppress metastasis and improve prognosis for patients with these cancers. In this research, we analyzed the clinical data and found that E3 ubiquitin ligase TRIM47 was upregulated in cancer tissues of hypopharyngeal cancer and was closely associated with poor survival outcomes. In terms of mechanism, we performed tandem affinity chromatography and denatured Ni‐NTA Agarose pulldown. As a result, TRIM47 was found to interact with vimentin and control vimentin stabilization through ubiquitination, specifically in the form of K63 chains. Importantly, through experiments of cancer cell viability and migration, we found that TRIM47 could enhance the proliferation and metastasis abilities of cancer cells in a vimentin‐dependent manner, thus promoting the advancement of hypopharyngeal and laryngeal cancers. TRIM47 was verified to regulate cancer cells metastasis in vivo using metastasis models. All these results imply that TRIM47 emerges as a potential biomarker for early diagnosis and metastasis prediction of hypopharyngeal and laryngeal cancers and represents a promising therapeutic target.
oncology
What problem does this paper attempt to address?